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Introduction
Subcellular localization of mRNAs can locally control the pro-
tein composition of distinct regions within the cell. Neurons pro-
vide an ideal system for understanding how subcellular mRNA 
localization is regulated. The widely separated cytoplasmic ex-
tents of neuronal dendrites, axons, and cell body allow one to ask 
how local extracellular stimuli may alter populations of localized 
mRNAs and ultimately modulate the local protein composition 
of that subcellular domain. Much recent effort has focused on 
how neuronal RNA traffi  cking and localized translation are regu-
lated (Tiedge, 2005; Bassell and Twiss, 2006; Martin and Zukin, 
2006). Transport of mRNAs and translational machinery into 
axons along with subsequent local protein synthesis is needed to 
initiate growth responses and for growing neurons to respond 
to environmental stimuli (Campbell and Holt, 2001, 2003; Ming 
et al., 2002; Brunet et al., 2005; Piper et al., 2005, 2006; Verma 
et al., 2005; Wu et al., 2005; Leung et al., 2006; Yao et al., 2006).
Despite increasing knowledge of stimuli that can trigger 
axonal protein synthesis, knowledge of the specifi  city of these 
autonomous responses has been quite limited (Piper and Holt, 
2004). Injury of peripheral axons triggers localized translation of 
importin β and vimentin mRNAs, and these nascent protein 
products generate a retrograde signaling complex (Hanz et al., 
2003; Perlson et al., 2005). In cultures of developing neurons, the 
guidance cue semaphorin 3A (Sema3A) activates the localized 
translation of RhoA mRNA (Wu et al., 2005), and neurotrophins 
increase the localized synthesis of axonal β-actin (Zhang et al., 
1999). A study aimed at determining the scope of locally synthe-
sized proteins argues that axons have the potential to synthesize 
many different proteins (Willis et al., 2005), raising the questions 
of if and how the expression of these proteins may be regulated 
in the axonal compartment.
In addition to translational control, regulating the delivery 
of mRNAs to subcellular regions can modulate localized protein 
synthesis by altering which mRNAs are locally available for 
translation. Evidence for this is seen in cultures of developing 
cortical neurons in which bath application of neurotrophins can 
increase the delivery of β-actin mRNA to the axonal growth cone 
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  S
ubcellular regulation of protein synthesis requires 
the correct localization of messenger RNAs (mRNAs) 
within the cell. In this study, we investigate whether 
the axonal localization of neuronal mRNAs is regulated by 
extracellular stimuli. By proﬁ  ling axonal levels of 50 mRNAs 
detected in regenerating adult sensory axons, we show 
that neurotrophins can increase and decrease levels of ax-
onal mRNAs. Neurotrophins (nerve growth factor, brain-
derived neurotrophic factor, and neurotrophin-3) regulate 
axonal mRNA levels and use distinct downstream signals 
to localize individual mRNAs. However, myelin-associated 
glycoprotein and semaphorin 3A regulate axonal levels of 
different mRNAs and elicit the opposite effect on axonal 
mRNA levels from those observed with neurotrophins. The 
axonal mRNAs accumulate at or are depleted from points 
of ligand stimulation along the axons. The translation prod-
uct of a chimeric green ﬂ  uorescent protein–β-actin mRNA 
showed similar accumulation or depletion adjacent to stim-
uli that increase or decrease axonal levels of endogenous 
β-actin mRNA. Thus, extracellular ligands can regulate 
protein generation within subcellular regions by speciﬁ  -
cally altering the localized levels of particular mRNAs.
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(Zhang et al., 1999). In the present study, we show that the levels 
of individual axonal mRNAs are differentially regulated by the 
local stimulation of axons with growth-promoting and growth-
inhibiting stimuli. Quantitative analyses of axonal mRNAs showed 
that nerve growth factor (NGF), brain-derived neurotrophic 
factor (BDNF), neurotrophin-3 (NT3), myelin-associated glyco-
protein (MAG), and Sema3A can specifi  cally increase or decrease 
levels of individual transcripts. These alterations in axonal mRNA 
levels were accompanied by opposite changes in the cell body 
mRNA levels, suggesting that ligand-dependent alterations in 
anterograde transport rates exist. With in situ hybridization and 
heterologous expression of a chimeric mRNA containing the rat 
β-actin mRNA localization element, the alterations in axonal 
mRNA levels seen by quantitative analyses correspond to the 
relative enrichment or depletion of individual mRNAs from 
axonal regions directly adjacent to ligand sources. These fi  ndings 
argue that diverse extracellular signals bidirectionally regulate 
the transport of numerous mRNAs within axons to infl  uence local 
protein synthesis.
Results
Scope of proteins locally synthesized 
in the rat sensory axons
We previously used a proteomics approach to identify locally 
synthesized proteins from cultures of adult rat dorsal root gan-
glion (DRG) neurons (Willis et al., 2005). This approach was 
limited to the most abundant axonally synthesized proteins. 
 Because we were able to view only a fraction of the axonal mRNAs 
using this method, we reasoned that a more global assessment of 
axonal mRNA content would be needed to test for the specifi  c 
regulation of axonal mRNA localization. For this, axonal RNA 
was isolated from dissociated cultures of DRG neurons after 
20–22 h in vitro as previously described (Zheng et al., 2001). The 
L4-5 DRGs were conditioned by in vivo sciatic nerve crush 7 d 
before culture. These injury-conditioned sensory neurons show 
rapid transcription-independent, translation-dependent process 
outgrowth over 24 h in culture (Smith and Skene, 1997; Twiss 
et al., 2000). The purity of axonal preparations was verifi  ed by 
the absence of γ-actin and microtubule-associated protein 2 
mRNAs (Fig. S1, available at http://www.jcb.org/cgi/content/full/
jcb.200703209/DC1; Zheng et al., 2001; Willis et al., 2005). 
Amplifi  ed cDNAs prepared from axonal RNAs were used to 
hybridize to Atlas cDNA arrays containing  4,000 rat cDNAs. 
Localized mRNAs detected from hybridizations of four separate 
axonal preparations are summarized in Table S1. According to 
these data, the injury-conditioned DRG axons have the capacity 
to synthesize >200 different proteins, including transmembrane 
proteins (e.g., Kv3.1a and HCN4) and components of the trans-
lational machinery (e.g., ribosomal proteins) that were not detected 
in our previous proteomics screen (Willis et al., 2005).
Axonal mRNA levels can be positively 
and negatively regulated by peripheral 
stimulation with chemotropic agents
Guidance cues that invoke axon turning or collapse have been 
shown to regulate axonal protein synthesis (Campbell and Holt, 
2001, 2003; Ming et al., 2002; Piper et al., 2005). To determine 
whether axonal mRNA localization is specifi  cally regulated in 
the DRG neurons, we asked whether the local application of 
growth-promoting or growth-inhibiting stimuli to DRG axons 
can alter the localization of individual mRNAs. A panel of 50 
axonal mRNAs from the aforementioned array data and a previ-
ous proteomics study (Willis et al., 2005), which broadly repre-
sents axonal mRNAs encoding different protein types, was used 
for these analyses. Neurotrophins were chosen for the growth-
promoting ligands because their TrkA, TrkB, and TrkC recep-
tors are expressed by all of the DRG neurons (Snider, 1994). 
Sema3A and MAG were used as growth-inhibitory stimuli be-
cause these ligands induce axonal retraction or repulsion in rat 
DRG neurons (Shen et al., 1998; Li et al., 2004). The axonal 
compartment was exposed to ligands immobilized on micro-
particles for 4 h in the presence of the RNA polymerase II inhibitor 
5,6-dichlorobenzimidazole riboside (DRB). Microparticles with 
immobilized BSA, AP, or human IgG Fc domain were used as 
controls for the neurotrophin, Sema3A, and MAG, respectively. 
Axonal mRNA levels for each of the 50 transcripts were deter-
mined using axonal RNA isolates for reverse transcription fol-
lowed by quantitative PCR (qPCR). The qPCR results are detailed 
in Table I. These data show both ligand and transcript specifi  city 
for the regulation of axonal mRNA levels.
Fig. 1 summarizes changes in axonal levels for a few mRNAs 
to illustrate the specifi  city of these ligand-dependent responses. 
Note that each stimulus can increase or decrease axonal levels 
of an individual mRNA. For the neurotrophins, NGF and BDNF 
showed an overall similar regulation of axonal mRNA levels 
except for 43-kD growth-associated protein (GAP-43) mRNA, 
which was uniquely affected by NGF (Fig. 1 A). NT3 modu-
lation of axonal mRNA levels appeared distinct from NGF and 
BDNF. For example, axonal levels of the mRNA encoding the 
Kv3.1a potassium channel was decreased by NGF and BDNF, 
but NT3 increased axonal levels of Kv3.1a mRNA (Fig. 1 A). 
Similar to the neurotrophins, MAG and Sema3A increased and 
decreased the localization of individual axonal mRNAs (Fig. 1 B). 
With the exception of vimentin mRNA, MAG and Sema3A 
altered axonal mRNA levels distinctly from the neurotrophins 
(Fig. 1 B and Table I). For example, Sema3A and MAG de-
creased axonal β-actin mRNA levels, whereas the neurotrophins 
consistently increased axonal β-actin mRNA levels. Several 
transcripts that were not responsive to the neurotrophins showed 
altered axonal levels with MAG and/or Sema3A (Table I). Inter-
estingly, many of the mRNAs tested showed no signifi  cant 
change (P > 0.01) in response to the 4-h ligand stimulation 
(Table I). This result, combined with the differences in axonal 
mRNA levels seen among the individual neurotrophins, indicates 
that the regulation of mRNA localization is highly specifi  c at 
the level of individual transcripts and for ligands that   activate 
similar intracellular signaling pathways.
Ligand-induced changes in axonal mRNAs 
change cell body mRNA content
Over the 4-h period used to stimulate the aforementioned axons, 
DRB decreased new RNA synthesis >90% based on the in-
corporation of α-[
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Table I. Modulation of axonal mRNA levels in response to growth-promoting and growth-inhibiting stimuli
mRNA NGF BDNF NT3 MAG Sema3A
αB crystallin 1.22 ± 0.10 1.17 ± 0.08 1.20 ± 0.16 4.59 ± 0.24 5.03 ± 0.13
Aldolase C 1.04 ± 0.07 −1.09 ± 0.04 −1.75 ± 0.14 −1.30 ± 0.25 −1.52 ± 0.21
Amphoterin 1.03 ± 0.19 1.04 ± 0.14 1.05 ± 0.18 −1.03 ± 0.16 −1.08 ± 0.15
ATP synthase 1.31 ± 0.07 1.06 ± 0.09 −1.92 ± 0.14 1.06 ± 0.09 1.21 ± 0.22
β-actin 4.14 ± 0.48 4.41 ± 0.38 2.17 ± 0.13 −1.30 ± 0.16 −1.38 ± 0.19
CACNA1 −1.45 ± 0.11 −1.56 ± 0.12 −1.19 ± 0.14 1.12 ± 0.09 1.28 ± 0.21
Calmodulin (RCM3) 1.13 ± 0.18 1.05 ± 0.25 −1.00 ± 0.16 1.10 ± 0.18 1.08 ± 0.20
Calreticulin 1.06 ± 0.10 1.21 ± 0.40 2.22 ± 0.06 2.73 ± 0.15 4.20 ± 0.09
Cathepsin B −1.04 ± 0.12 −1.06 ± 0.15 1.01 ± 0.11 1.04 ± 0.13 1.06 ± 0.17
Coﬁ  lin 1.13 ± 0.05 1.04 ± 0.09 1.19 ± 0.06 −1.06 ± 0.09 −1.03 ± 0.08
CsA 1.15 ± 0.06 −1.07 ± 0.19 −1.54 ± 0.06 1.13 ± 0.12 −1.31 ± 0.07
Cyclophilin A 1.07 ± 0.16 1.04 ± 0.20 1.06 ± 0.17 −1.03 ± 0.16 −1.18 ± 0.15
Cystatin C 1.13 ± 0.12 1.02 ± 0.14 −1.04 ± 0.15 1.01 ± 0.20 1.01 ± 0.16
Ddah2 −1.03 ± 0.13 −1.07 ± 0.15 −1.52 ± 0.16 1.43 ± 0.11 1.13 ± 0.02
Enolase 1.32 ± 0.08 1.35 ± 0.14 −1.05 ± 0.09 1.19 ± 0.12 −1.58 ± 0.19
ERp29 −1.01 ± 0.08 1.03 ± 0.07 1.17 ± 0.09 1.18 ± 0.09 −1.08 ± 0.09
GAP43 2.25 ± 0.06 1.13 ± 0.13 −1.01 ± 0.05 −1.09 ± 0.08 −1.13 ± 0.08
GAPDH 1.07 ± 0.09 1.03 ± 0.04 −1.03 ± 0.13 −1.01 ± 0.19 −1.05 ± 0.12
grp75 −1.15 ± 0.07 −1.05 ± 0.07 1.24 ± 0.20 1.09 ± 0.16 1.14 ± 0.08
grp78/BiP −1.03 ± 0.07 1.05 ± 0.10 1.23 ± 0.08 1.67 ± 0.15 1.47 ± 0.22
γ-Synuclein −1.03 ± 0.07 1.02 ± 0.13 −1.56 ± 0.05 1.01 ± 0.15 −1.01 ± 0.06
γ-Tropomyosin 3 1.03 ± 0.07 1.03 ± 0.07 −1.47 ± 0.06 1.13 ± 0.10 −1.69 ± 0.05
HCN4 −1.40 ± 0.17 −1.35 ± 0.09 1.17 ± 0.21 1.21 ± 0.16 2.07 ± 0.21
hnRNPH’ 1.02 ± 0.06 1.03 ± 0.10 −1.03 ± 0.08 1.23 ± 0.15 −1.13 ± 0.13
HSP27 1.08 ± 0.21 −1.03 ± 0.16 −1.56 ± 0.08 −1.44 ± 0.14 1.05 ± 0.09
HSP60 −1.13 ± 0.07 −1.13 ± 0.09 2.36 ± 0.23 1.46 ± 0.13 2.45 ± 0.21
HSP70 1.01 ± 0.06 −1.09 ± 0.05 −2.27 ± 0.13 −1.10 ± 0.16 1.38 ± 0.17
HSP90 −1.03 ± 0.07 1.03 ± 0.08 −2.08 ± 0.11 2.53 ± 0.28 3.32 ± 0.14
Importin β1 1.06 ± 0.11 1.03 ± 0.05 1.09 ± 0.15 1.06 ± 0.09 1.05 ± 0.07
Kv3.1a −1.79 ± 0.13 −1.89 ± 0.12 2.14 ± 0.10 −1.04 ± 0.14 −1.03 ± 0.20
Lipocortin 2 1.06 ± 0.07 1.04 ± 0.09 1.01 ± 0.07 1.04 ± 0.08 1.09 ± 0.09
Neuritin 1.07 ± 0.11 1.06 ± 0.16 1.00 ± 0.12 1.13 ± 0.13 1.08 ± 0.09
NMP35 −1.04 ± 0.06 −1.04 ± 0.17 1.05 ± 0.14 1.10 ± 0.17 1.13 ± 0.11
PEBP 1.09 ± 0.08 −1.03 ± 0.11 −1.45 ± 0.11 1.14 ± 0.15 1.52 ± 0.16
Peripherin 2.85 ± 0.20 2.85 ± 0.13 −1.32 ± 0.03 1.09 ± 0.19 1.11 ± 0.11
Pgk1 1.03 ± 0.19 1.13 ± 0.16 −1.13 ± 0.21 3.92 ± 0.13 −1.10 ± 0.06
Prdx1 −1.03 ± 0.10 1.28 ± 0.04 −1.10 ± 0.16 1.48 ± 0.17 1.36 ± 0.08
Prdx6 1.08 ± 0.26 1.03 ± 0.21 −1.23 ± 0.05 1.29 ± 0.11 1.14 ± 0.09
RP-L11 −1.13 ± 0.11 −1.09 ± 0.12 −1.04 ± 0.15 1.10 ± 0.13 1.15 ± 0.16
RP-L22 3.10 ± 0.07 2.85 ± 0.08 1.26 ± 0.11 −1.13 ± 0.21 −1.98 ± 0.20
RP-L24 2.66 ± 0.07 3.01 ± 0.07 1.16 ± 0.19 −1.10 ± 0.11 −1.05 ± 0.11
RP-L37 −1.08 ± 0.13 −1.13 ± 0.17 −1.09 ± 0.19 −1.08 ± 0.19 −1.13 ± 0.18
RP-S17 2.50 ± 0.10 2.60 ± 0.10 1.09 ± 0.07 −1.14 ± 0.09 −1.12 ± 0.12
RP-S23 −1.13 ± 0.09 −1.17 ± 0.08 −1.15 ± 0.10 1.05 ± 0.10 −1.01 ± 0.09
RVDAC3 −1.03 ± 0.08 −1.04 ± 0.10 −1.61 ± 0.17 1.38 ± 0.15 −1.01 ± 0.08
SOD1 1.13 ± 0.10 1.31 ± 0.16 −1.01 ± 0.08 1.56 ± 0.12 1.58 ± 0.16
Sp22 (DJ-1) 1.12 ± 0.16 1.01 ± 0.14 2.28 ± 0.15 1.03 ± 0.16 2.19 ± 0.05
Tα1 tubulin 1.09 ± 0.08 1.15 ± 0.07 −1.09 ± 0.06 1.44 ± 0.09 1.20 ± 0.11
Thymosin β-4 1.95 ± 0.06 1.87 ± 0.07 −1.64 ± 0.11 1.01 ± 0.11 −1.82 ± 0.14
UchL1 1.08 ± 0.12 1.03 ± 0.15 1.07 ± 0.12 1.09 ± 0.07 1.11 ± 0.19
Vimentin 3.56 ± 0.01 3.94 ± 0.21 1.01 ± 0.07 5.28 ± 0.16 4.72 ± 0.09
qPCR data for the axonal mRNAs tested for axonal level modulation by NGF, BDNF, NT3, MAG, and Sema3A are tabulated. Axonal levels of the mRNAs are compared 
with axons treated with controls (BSA for NGF, BDNF, and NT-3; IgG-Fc for MAG; and AP for Sema3A) and are displayed ± SD from three replicates. Values in bold indicate 
differences that were statistically signiﬁ  cant based on P < 0.01 by the student Newman-Keul test. The other values are not statistically signiﬁ  cant (P ≥ 0.01).JCB • VOLUME 178 • NUMBER 6 • 2007  968
injury-conditioned DRGs (Fig. S2 A, available at http://www.jcb
.org/cgi/content/full/jcb.200703209/DC1). Although we cannot 
exclude the possibility that alterations in axonal mRNA stability 
contributed to the changes in axonal mRNA levels, these meta-
bolic labeling experiments suggest that chemotropic agents can 
alter the localization of existing mRNA populations. If this is the 
case, any transport-dependent changes in axonal mRNA levels 
should be accompanied by an opposite change in the levels of 
that transcript in the cell body. Although our previous analysis of 
cytoskeletal mRNAs did not show depletion of cell body levels 
after NGF-induced increases in mRNA levels in the axons, the 
high expression of cytoskeletal mRNAs in the DRG cultures 
could complicate the detection of cell body depletion during this 
and previous short-term experiments (Willis et al., 2005). To 
more rigorously test for ligand-dependent alterations in axonal 
mRNA content, we extended treatment duration from 4 to 12 h 
and evaluated axonal levels of a subset of mRNAs that showed 
increased or decreased axonal levels with NGF (Fig. 2). qPCR 
analyses of cell body and axonal RNA content showed that the 
decrease in axonal levels of Cav1.2 and Kv3.1a mRNAs seen af-
ter NGF exposure resulted in a statistically signifi  cant increase 
(P ≤ 0.01) in the cell body content of these mRNAs. In contrast, 
increased axonal levels of peripherin, RP-L22, RP-S17, and thy-
mosin β4 mRNAs resulted in decreased cell body mRNA con-
tent (Fig. 2). These data suggest that the sensory neurons draw 
on a pool of preexisting mRNAs in the cell body to alter the de-
livery of individual mRNAs into the axons in response to ligand 
stimulation. In addition, these data indicate that extracellular 
signals can lead to a new steady state in the distribution of spe-
cifi  c mRNAs between the cell body and axon that is likely inde-
pendent of transcription.
RNAs are transported on microfi  laments in fi  broblasts, 
whereas most other cellular systems, including neurons, have been 
shown to use microtubules for long-range transport of mRNAs 
(Sundell and Singer, 1990; Carson et al., 1997; Brumwell et al., 
2002; Oleynikov and Singer, 2003; Shan et al., 2003; Chang 
et al., 2006). To determine whether the neurotrophin-dependent 
changes in axonal mRNA levels in Fig. 1 A require intact cyto-
skeleton, dissociated cultures were pretreated with cytochalasin D 
or colchicine to disrupt microfilaments or microtubules, re-
spectively. For this analysis, we examined a subset of the transcripts 
Figure 1.  Axonal stimulation with growth-promoting and growth-inhibit-
ing stimuli alters axonal mRNA localization. (A and B) The changes in ax-
onal levels of representative mRNAs in response to NGF, BDNF, and NT-3 
(A) or MAG-Fc and Sema3A-AP (B) from Table I are graphically illustrated. 
Positive values indicate an increase in axonal mRNA content, and negative 
values indicate a decrease in axonal mRNA content detected by qPCR. The 
axonal mRNA values for neurotrophins are expressed relative to axons 
treated with BSA. Values for MAG are expressed relative to human IgG Fc, 
and those for Sema3A are expressed relative to AP (there were no statisti-
cally signiﬁ  cant differences between the Fc and AP controls; not depicted). 
Error bars represent the SD of three replicate experiments with each sam-
ple measured in quadruplicate. Signiﬁ  cance was calculated based on P ≤ 
0.01 by a student Newman-Keul test compared with the control. Note that 
the neurotrophins, MAG, and Sema3A selectively increase or decrease the 
transport of individual mRNAs. No statistically signiﬁ  cant changes were 
seen in axonal levels of αB crystallin, grp78/BiP, or HCN4 mRNAs with 
NGF, BDNF, or NT3 treatments. No statistically signiﬁ  cant changes were 
seen in axonal levels of GAP43, Kv3.1a, or peripherin mRNAs with MAG 
or Sema3A treatments.
Figure 2.  Alterations in axonal mRNA levels inversely affect cell body 
mRNA content. To determine whether altered transport from the cell body 
underlies the neurotrophin-mediated changes in axonal transcript levels, 
the axonal compartment of 16-h injury-conditioned DRG cultures was 
treated with NGF microparticles for 12 h. Duplicate cultures were treated, 
with one set of tissue culture inserts processed to isolate the axonal com-
partment RNA and the other set used to isolate the cell body compartment 
RNA. Levels of the indicated mRNAs were analyzed by qPCR as in Fig. 1. 
For each NGF-dependent change in levels of the axonal mRNA, an oppo-
site change in the levels of that transcript was seen in the cell body RNA 
sample. Error bars represent the SD of three replicate experiments with 
each sample measured in quadruplicate.CONTROL OF AXONAL MRNA LOCALIZATION • WILLIS ET AL. 969
shown in Table I that was comprised of fi  ve mRNAs with in-
creased transport with NGF, fi  ve mRNAs with decreased trans-
port with NGF, and fi  ve mRNAs with no response to NGF. The 
disruption of microfi  laments decreased the NGF-dependent 
alterations in axonal mRNA levels but not to the extent that was 
seen with the microtubule-depolymerizing agent (Fig. 3 A). 
Although colchicine treatment modestly reduced overall axonal 
mRNA levels, the NGF-induced changes in axonal levels were 
almost completely abolished by colchicine (Fig. 3 A). Specifi  c-
ity for the effect of colchicine on NGF-dependent RNA local-
ization is indicated by the lack of any effect of colchicine or 
cytochalasin D on the nonresponding mRNAs (Fig. 3 A). These 
observations further suggest that neurotrophins regulate axonal 
mRNA levels by altering the rates of transport of mRNAs from 
the cell body.
A change in delivery of mRNAs into axons with periph-
eral stimulation could require that instructive signals from the 
axons be retrogradely transmitted to the neuronal cell body (or 
nucleus). To determine whether the aforementioned alterations 
for mRNA levels require stimulus localized to the axonal com-
partment, we compared axonal mRNA levels after the applica-
tion of immobilized NGF to axons versus bath-applied NGF 
(i.e., soluble), which would simultaneously stimulate axonal 
and cell body compartments. Approximately equivalent levels 
of soluble versus immobilized ligand were applied based on 
our previous assessments of TrkA phosphorylation by the NGF 
microparticles (Willis et al., 2005). Roughly twofold more 
β-actin mRNA accumulated in the axons with local stimulation 
than with bath-applied NGF (Fig. 3 B). Peripherin and Kv3.1a 
mRNAs showed no response to bath-applied neurotrophins, 
Figure 3.  Axonal stimulation of mRNA locali-
zation is microtubule based. (A) To determine 
how mRNAs are transported into the axonal 
compartment, injury-conditioned DRG cultures 
were treated with cytochalasin D or colchicine 
for 30 min followed by exposure of the axonal 
compartment to NGF microparticles for 4 h as 
indicated. Levels of the axonal mRNAs indi-
cated were analyzed by qPCR as in Fig. 1. 
Disruption of microﬁ  laments with cytochalasin D 
caused minimal changes in NGF-induced ax-
onal transport. Disrupting microtubule-based 
transport with colchicine completely blocked 
NGF-dependent changes in axonal mRNA lev-
els, attenuating both the increase and decrease 
in axonal transport (*, P ≤ 0.01; student 
Newman-Keul test). (B) To determine whether the 
NGF-dependent changes in axonal mRNA trans-
port seen in Fig. 1 required a localized axonal 
source of NGF, cultures of injury-conditioned 
DRG neurons were exposed to 100 ng/ml 
NGF in solution versus exposing only the   axonal 
compartment to immobilized NGF correspond-
ing to a concentration of 100 ng/ml. DRG cul-
tures exposed to NGF in solution had a distinct 
response compared with the immobilized NGF 
treatment of the axonal compartment. With 
the exception of vimentin, those transcripts that 
were increased by the local application of NGF 
showed signiﬁ  cantly lower levels in response 
to the bath application of NGF (*, P ≤ 0.01; 
student Newman-Keul test). Those transcripts 
decreased in response to local NGF treatment, 
and some that had no response to NGF showed 
a variable but statistically different response 
to bath application (**, P ≤ 0.01; student 
Newman-Keul test). (A and B) Error bars repre-
sent the SD of three replicate experiments with 
each sample measured in quadruplicate.JCB • VOLUME 178 • NUMBER 6 • 2007  970
whereas axonal HCN4 mRNA appeared more sensitive to bath-
applied NGF than localized ligand sources. With bath applica-
tion of NGF, calreticulin, and HSP70 mRNAs, two transcripts 
that did not respond to localized NGF showed alterations in ax-
onal mRNA levels, indicating that these transcripts uniquely re-
spond to the soluble ligand (Fig. 3 B). Collectively, these data 
indicate that the stimulus derived from localized neurotrophin 
sources is qualitatively and quantitatively different from the 
nonlocalized stimulus of the soluble ligand.
Modulation of axonal mRNA localization 
through divergent signaling pathways
To determine the role of Trk receptors in neurotrophin-dependent 
axonal mRNA localization, cultures were pretreated with K252A 
at levels that specifi  cally inhibit Trk tyrosine kinase activity 
(Tapley et al., 1992). For the mRNAs that increased with axo-
nal NGF stimulation, K252A pretreated cultures showed axo-
nal levels that were nearly indistinguishable from neurons 
exposed to control microparticles (Fig. 4 A). Axonal levels of 
the fi  ve nonresponding transcripts were not affected by K252A 
treatment (Fig. 4 A). Surprisingly, mRNAs with NGF- dependent 
decreases in axonal content showed a complete reversal, exhib-
iting increased axonal levels with Trk inhibition and peripheral 
NGF stimuli (Fig. 4 A). Both Kv3.1a and HCN4 mRNAs, for 
which levels were decreased by  1.5-fold in the axons treated 
with NGF, showed a one- to twofold increase in axonal lev-
els in cultures treated with K252A (Fig. 4 A). This indicates 
that local sources of NGF can signal through Trk receptors 
to bidirectionally modulate the axonal localization of individ-
ual mRNAs.
Figure 4.  Divergent signaling pathways regu-
late axonal mRNA levels in response to neuro-
trophins.  (A) Injury-conditioned DRG cultures 
were pretreated with 200 nM K252A to inhibit 
Trk tyrosine kinase activity for 30 min before 
application of NGF microparticles to the ax-
onal compartment. Axonal mRNAs were ana-
lyzed by qPCR as in Fig. 1; the NGF-treated 
samples were normalized to the BSA control, 
and the K252A plus NGF-treated cultures are 
expressed relative to BSA plus K252A. K252A 
treatment altered the response to NGF micro-
particles, attenuating the increase in those mRNAs 
whose axonal levels were increased by neuro-
trophins. For transcripts that exhibited decreased 
axonal levels in response to NGF, K252A re-
versed the effect of NGF, resulting in increased 
axonal mRNA localization. (B) To evaluate 
  signaling events downstream of TrkA, injury-
conditioned DRG cultures were treated with 
MEK1 (PD98059) and PI3K (LY29004) inhib  itors 
for 30 min before exposing the axonal com-
partment to immobilized NGF. Axonal mRNA 
levels were analyzed by qPCR as in Fig. 1; the 
NGF-treated samples are normalized to the BSA 
control, and the PD98059 or LY294002 plus 
NGF-treated cultures are expressed relative to 
PD98059 or LY294002 plus BSA, respectively. 
NGF-induced axonal localization or depletion 
of the majority of mRNAs was attenuated or re-
versed by inhibition of the MAPK pathway with 
PD98059. Two transcripts behaved differently. 
The depletion of axonal Kv3.1a mRNA by NGF 
was completely reversed by the inhibition of 
PI3K, and the increased levels of β-actin mRNA 
seen with NGF treatment was blocked equally 
well by the inhibition of MEK1 or PI3K. (A and B) 
Error bars represent the SD of three replicate 
experiments with each sample measured in 
quadruplicate (*, P ≤ 0.01; student Newman-
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The neurotrophin-dependent activation of phosphatidyl 
inositol-3 kinase (PI3K) and Ras–MAPK pathways contribute 
to the local trophic and tropic effects of NGF and other neuro-
trophins (Segal, 2003). We used pretreatment with MEK1 and 
PI3K inhibitors (PD98059 and LY29004, respectively) to test 
whether these signaling pathways play a role in the neuro-
trophin-dependent regulation of axonal mRNA localization. The 
fi  ve mRNAs that previously did not respond to NGF remained 
unaffected overall by PD98059 and LY29004, indicating that 
basal activity of PI3K and MEK1 did not contribute to their axo-
nal localization (Fig. 4 B). For most of the regulated mRNAs, 
NGF’s effects on their axonal levels were attenuated by inhibi-
tion of the MAPK pathway with PD98059 (Fig. 4 B). However, 
two transcripts behaved differently. The NGF-dependent attenu-
ation of Kv3.1a mRNA’s axonal localization required PI3K ac-
tivity but was unaffected by the MEK1 inhibitor (Fig. 4 B). The 
increased axonal localization of β-actin mRNA seen with NGF 
was attenuated by the inhibition of either PI3K or MEK1 (Fig. 
4 B). All other mRNAs that localized in response to NGF (e.g., 
vimentin and peripherin) required MEK1 but not PI3K (Fig. 
4 B). Thus, a single ligand can uniquely regulate the axonal 
  localization of individual mRNAs using different downstream 
signaling pathways.
Focal ligand sources instruct the neuron 
where and where not to localize mRNAs 
within axons
Although extremely sensitive, the reverse transcription qPCR 
method used in Figs. 1–4 provides no information on where 
mRNAs are localized within the axon. Because axonal β-actin 
mRNA showed divergent regulation with growth-promoting 
versus growth-inhibiting stimuli and appeared more sensitive to 
localized ligand sources, we used the well-characterized local-
ization elements of β-actin mRNA to drive the axonal localiza-
tion of heterologous mRNAs encoding a reporter protein. For 
this, the 3′ untranslated region (UTR) of enhanced GFP
NLS/myr 
(eGFP
NLS/myr; Aakalu et al., 2001) was replaced with 3′ UTRs 
from the rat β-actin or γ-actin mRNAs (eGFP
NLS/myrβ-actin and 
eGFP
NLS/myrγ-actin, respectively). β-actin mRNA 3′ UTR con-
tains a zipcode element that directs the transport of this mRNA 
in fi  broblasts, myocytes, and neurons; γ-actin mRNA does not 
contain any similar element, and the transcript is retained in 
the perinuclear region (Lawrence and Singer, 1986; Kislauskis 
et al., 1994; Bassell et al., 1998). To facilitate expression in 
the adult DRG neurons, we generated adenoviruses (AVs) that 
  express these reporter cDNAs (AV-eGFP
NLS/myrγ-actin and 
AV-eGFP
NLS/myrβ-actin). In injury-conditioned DRG cultures 
infected with AV-eGFP
NLS/myrγ-actin, reporter fl  uorescence ac-
cumulated in the cell body and did not extend into the axonal 
compartment (Fig. S3, available at http://www.jcb.org/cgi/ 
content/full/jcb.200703209/DC1). In contrast, GFP signal was seen 
in the cell body and at foci along the axonal processes, includ-
ing the growth cones in cultures infected with AV-eGFP
NLS/myr 
β-actin (Fig. S3). The myr domain of this eGFP
NLS/myr construct 
likely restricts diffusion of the eGFP product in the axonal com-
partment, providing a measure of localized protein synthesis as 
previously reported (Aakalu et al., 2001). RT-PCR from axonal 
RNA also confi  rmed the differential localization of eGFP
NLS/myr
β-actin versus eGFP
NLS/myrγ-actin mRNAs in the DRG cultures 
(unpublished data). Thus, similar to axons of developing corti-
cal neurons (Zhang et al., 1999; Gu et al., 2002), the 3′ UTR of 
β-actin mRNA is suffi  cient for axonal localization in adult rat 
sensory neurons.
Because the β-actin 3′ UTR appeared to direct axonal 
localization of eGFP mRNA in the DRG cultures, we next con-
sidered whether axonal localization of eGFP
NLS/myrβ-actin is 
modulated by growth-promoting and growth-inhibiting stimuli. 
Analyses of axons exposed to NGF microparticles showed that 
GFP signals under the control of β-actin 3′ UTR accumulated 
directly adjacent to the ligand source during a 50-min exposure 
(Fig. 5 A and Video 1, available at http://www.jcb.org/cgi/ 
content/full/jcb.200703209/DC1). Axons typically showed a 
sprouting or turning response upon contact with NGF micro-
particles (Fig. S4). BSA microparticles did not affect the intensity 
of GFP signals or the directionality of axonal growth (Fig. S4). 
At the completion of a 50-min exposure, axonal GFP fl  uores-
cence was signifi  cantly greater adjacent to NGF when compared 
with BSA microparticles  (5.29 ± 0.07-fold for NGF vs. BSA; 
P ≤ 0.001). Although there is an inherent experimental delay in 
when video sequences can be initiated with this approach (i.e., 
as the particles settle onto the coverslip), there was also a con-
sistent increase in GFP fl  uorescence adjacent to NGF micro-
particles over the course of the imaging sequences (1.6 ± 0.09-fold 
for t = 50 vs. t = 0 min; P ≤ 0.001). Similar to the effects of 
  kinase inhibitors upon the endogenous β-actin mRNA shown 
in Fig. 4, the inhibition of Trk or downstream MEK1 or PI3K 
activity prevented any GFP accumulation adjacent to the NGF 
source (Figs. 5 B and S4 and Video 2). Thus, the dynamic re-
distribution of mRNA likely directly impacts the translation and 
accumulation of protein.
Microtubule-depolymerizing agents were used to deter-
mine whether an increase in GFP
NLS/myrβ-actin signals was the 
result of RNA accumulation at NGF sources. No NGF-dependent 
accumulation of GFP was seen in cultures exposed to colchi-
cine (Fig. 5 C and Video 3, available at http://www.jcb.org/
cgi/content/full/jcb.200703209/DC1). The continued increase 
in GFP signals in the growth cone (distal to NGF source) indi-
cates that the colchicine treatment did not affect translation of 
the eGFP
NLS/myrβ-actin mRNA that had already accumulated in 
the growth cone. Because colchicine completely blocked NGF-
dependent increases in axonal β-actin mRNA levels in the qPCR 
experiments (Fig. 3 A), the majority of the increased GFP signals 
shown in Fig. 5 A can be attributed to the subcellular localiza-
tion of eGFP
NLS/myrβ-actin mRNA rather than to the translational 
activation of any eGFP
NLS/myrβ-actin mRNA already residing 
within the axon.
Because microtubule depolymerization would alter both 
retrograde and anterograde transport, we tested whether the 
NGF effect on eGFP
NLS/myrβ-actin required retrograde signaling. 
For this, DRG cultures were transfected with dynein heavy 
chain (Dync1h1) siRNAs (He et al., 2005). The transfected 
  cultures showed a decrease of Dync1h1 protein, and trans-
fected neurons showed a selective depletion of retrograde but 
not anterograde transport (Fig. S2 B and Video 4, available at JCB • VOLUME 178 • NUMBER 6 • 2007  972
http://www.jcb.org/cgi/content/full/jcb.200703209/DC1). These 
siRNA-transfected neurons also showed no signifi  cant altera-
tion (P > 0.05) in eGFP
NLS/myrβ-actin signals over 50 min of ex-
posure to NGF microparticles (0.91 ± 0.11-fold for NGF vs. BSA; 
Fig. 5 D). DRG cultures treated with erythro-9-(2-hydroxy-3-
nonyl)adenine hydrochloride (EHNA), which has been shown 
to inhibit dynein ATPase activity (Ekstrom and Kanje, 1984; 
Shpetner et al., 1988), had similar depletion of retrograde trans-
port (Video 5) and showed no signifi  cant change (P > 0.05) in 
axonal GFP fl  uorescence in response to NGF (0.95 ± 0.10-fold 
for NGF vs. BSA). Thus, the NGF-dependent increase in local-
ization of the axonal reporter mRNA appears to require retro-
grade transport.
To determine how growth-inhibiting stimuli can deplete 
axonal β-actin mRNA levels, we examined the effect of immo-
bilized MAG on axonal GFP signals in AV-eGFP
NLS/myrβ-actin–
infected DRG cultures. GFP signals were relatively excluded 
from axonal regions adjacent to MAG sources (Fig. 6 A and 
Video 6, available at http://www.jcb.org/cgi/content/full/jcb
.200703209/DC1) and often caused the axon to turn away from 
the MAG source (Fig. S4). After 50-min exposure to microparti-
cles, GFP signals were signifi  cantly decreased with MAG-Fc 
microparticles when compared with the control IgG Fc micro-
particles (0.68 ± 0.1-fold for MAG-Fc vs. IgG Fc; P ≤ 0.001). 
The eGFP
NLS/myrβ-actin translation product was relatively de-
pleted from the vicinity of MAG-Fc (Fig. S4); this focal exclu-
sion of GFP adjacent to MAG sources is likely why MAG caused 
only a small reduction in β-actin mRNA by qPCR. In contrast to 
NGF’s effects on eGFP
NLS/myrβ-actin signals, a statistically sig-
nifi  cant attenuation of axonal GFP signals adjacent to MAG 
stimuli was still seen when retrograde transport was inhibited 
with Dync1h1 siRNA (0.75 ± 0.07-fold for MAG vs. IgG Fc; P ≤ 
0.01; Fig. 6 B) or EHNA (0.73 ± 0.12-fold for MAG vs. IgG Fc; 
P ≤ 0.01; not depicted). Thus, the MAG-dependent depletion 
of GFP signals appeared to be a local effect adjacent to axo-
nal stimuli.
Figure 5. eGFP
NLS/myr𝗃-actin translation product accumulates adjacent to NGF sources through instructive changes in the localization of its mRNA. Naive 
DRG cultures were infected with AV-eGFP
NLS/myrβ-actin and exposed to NGF microparticles (gray) after 2 d in culture. The images show GFP signal from 
confocal images through the distal axon collected beginning  20 min after ligand addition (to allow the microparticles to settle) and continuing for 50 min 
of live cell imaging with images collected at 1-min intervals. Still images at 10-min intervals are shown. GFP signal is displayed as a spectrum, as indicated 
in the ﬁ  nal panel of sequence C. (A) NGF microparticles caused GFP signal accumulation directly adjacent to the NGF stimulus (Video 1, available at 
http://www.jcb.org/cgi/content/full/jcb.200703209/DC1). In the latter portions of the sequence, a branch point with intense GFP signal can be seen 
directly adjacent to the microparticle (arrows). (B) Pretreatment with PD98059 prevented any change in GFP signal intensity at the site of contact with the 
NGF microparticle (Video 2). (C) Treatment with colchicine attenuated any change in GFP signal intensity adjacent to NGF microparticles compared with 
A (Video 3). (D) DRG cultures treated with dync1h1 siRNA showed decreased retrograde transport of LysoTracker dye (Video 4) and no change in GFP sig-
nal over a 50-min exposure to NGF microparticles. The images shown here are representative of at least 30 observations per condition with ≥80% con-
cordance between experimental observations. Bars, 5 μm.CONTROL OF AXONAL MRNA LOCALIZATION • WILLIS ET AL. 973
The growth-inhibitory effects of MAG can be overcome 
by elevating neuronal cAMP levels (Cai et al., 1999, 2001; 
Neumann et al., 2002). To determine whether the MAG-dependent 
changes in the localized production of eGFP
NLS/myrβ-actin could 
be altered by cAMP, cultures were treated with a cell-permeable 
nonhydrolyzable cAMP analogue (dibutyral cAMP [db-cAMP]) 
before exposure of axons to immobilized MAG. In db-cAMP–
treated cultures, eGFP
NLS/myrβ-actin signals accumulated directly 
adjacent to the MAG microparticles (Fig. 6 C and Video 7, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200703209/DC1). 
The GFP signals showed a signifi  cant increase adjacent to MAG-Fc 
microparticles after cAMP treatment when compared with 
IgG Fc control (4.47 ± 0.06-fold for MAG-Fc + db-cAMP vs. 
IgG Fc + db-cAMP; P ≤ 0.001), and, similar to the NGF re-
sponse, axons turned acutely after contact with the MAG micro-
particles (Fig. S4). Pretreatment with db-cAMP did not alter the 
response seen by contact with NGF or control microparticles 
(unpublished data).
Ligand-dependent localization of 
endogenous axonal mRNAs
FISH was used to determine whether focal stimulation of axons 
with growth-promoting versus growth-inhibiting ligands could 
similarly alter the local accumulation of endogenous mRNAs 
in these axons. For this, injury-conditioned DRGs were plated 
onto laminin-coated coverslips with adherent neurotrophin, MAG, 
and Sema3A microparticles. After 18 h in culture, cells were 
fi  xed and analyzed by FISH for mRNA and immunofl  uores-
cence for neurofi  lament. Differences in mRNA signal intensity 
adjacent to the immobilized agent were specifi  c both at the level 
of the transcript and ligand. Consistent with the transfected 
eGFP
NLS/myrβ-actin, endogenous β-actin mRNA was enriched 
adjacent to neurotrophin sources and decreased adjacent to MAG 
and Sema3A sources (Fig. 7 A). The disparity between the re-
sponses elicited by NGF and NT3 seen in the qPCR experiments 
for peripherin and Kv3.1a mRNAs was also evident in the local-
ization of these transcripts along axons exposed to immobilized 
NGF and NT3. Peripherin mRNA increased at the site of NGF 
stimuli but decreased adjacent to NT3 stimuli (Fig. 7 B). The 
opposite pattern was seen with Kv3.1a mRNA: FISH signals for 
Kv3.1a were decreased adjacent to NGF stimuli but increased 
adjacent to NT3 stimuli (Fig. 7 C). Together, these fi  ndings show 
that the exquisite ligand specifi  city for mRNA localization seen 
in the qPCR experiments corresponded to localized accumula-
tion or depletion of individual transcripts directly at the site of 
ligand exposure.
Discussion
Targeting mRNAs and translational machinery to subcellular loci 
is being increasingly recognized as a means to locally control the 
protein composition of cellular domains. Modulating the levels 
Figure 6. eGFP
NLS/myr𝗃-actin translation product is relatively excluded from regions adjacent to MAG sources. Naive DRG cultures were infected with 
AVeGFP
NLS/myrβ-actin as in Fig. 5. After 2 d, cultures were exposed to MAG microparticles. Image sequences were acquired for the indicated intervals be-
ginning at 20 min after the addition of microparticles. GFP signal is displayed as a spectrum (see ﬁ  nal panel in series B). (A) DRGs exposed to MAG micro-
particles show the exclusion of GFP signal adjacent to MAG stimulus. Coincident with the decrease in eGFP
NLS/myrβ-actin mRNA translation, the axon begins 
to retract upon contact with the MAG microparticle (Video 6, available at http://www.jcb.org/cgi/content/full/jcb.200703209/DC1). (B) In dync1h1 
siRNA-treated cultures, focal sources of MAG resulted in a decrease in GFP signal over the 50-min video sequence. (C) Pretreatment with db-cAMP reversed 
the response to MAG microparticles with an accumulation of GFP directly adjacent to the MAG (Video 7). The images shown here are representative of at 
least 30 observations per condition with ≥ 80% concordance between experimental observations. Bars, 5 μm.JCB • VOLUME 178 • NUMBER 6 • 2007  974
of individual mRNAs in different subcellular regions could alter 
the populations of proteins generated in these regions by locally 
altering the availability of templates for the local translational 
machinery. Because of the distances separating neuronal pro-
cesses from their cell body, neurons are an appealing cellular 
model for testing how local stimuli alter the traffi  cking of mRNAs 
into subcellular regions. Both the dendritic and axonal compart-
ments of neurons have been used to study the localization of sin-
gle transcripts, but the specifi  city of such changes has not been 
addressed for a broad population of mRNAs. Localized protein 
Figure 7.  Axonal mRNA levels are altered at the site of tropic stimulation. (A–C) Injury-conditioned DRGs were grown in the presence of focal immobilized 
sources of attractive or repulsive chemotropic agents for 18 h and analyzed by FISH for β-actin (A), peripherin (B), or Kv3.1a mRNA (C). Representative 
differential interference contrast and ﬂ  uorescent signals for mRNAs are illustrated for each indicated condition. The DRG processes were visualized 
by immunoﬂ  uorescence for neuroﬁ  lament heavy subunit (not depicted). The differential interference contrast images are focused on the microparticle to show 
the bead position relative to the axon. The bar graphs show relative axonal mRNA signal intensity in 5-μm bins that were normalized to the mean signal inten-
sity across the axon (an x-axis value of 0 indicates the 5-μm bin that bisected the microparticle; proximal negative numbers indicate the proximal axon, 
and positive numbers indicate the distal axon). Quantitative data were obtained from three separate experiments, and error bars represent the SD of 30 in-
dividual axons measured over these repetitions by a blinded observer. Fold differences are indicated in bins that are signiﬁ  cantly different compared with 
the most proximal segment (P ≤ 0.01; student Newman-Keul test). Bars, 5 μm.CONTROL OF AXONAL MRNA LOCALIZATION • WILLIS ET AL. 975
synthesis has been shown to provide a means for axons to auton-
omously respond to guidance cues and injury (Willis and Twiss, 
2006). Studies showing altered translation in axons have either 
not provided any analyses of which proteins are locally generated 
or have focused on single proteins (Wu et al., 2003; Piper and 
Holt, 2004; Wu et al., 2005; Leung et al., 2006; Piper et al., 2006; 
Yao et al., 2006). In the present study, we show that both growth-
promoting and growth-inhibiting stimuli can differentially local-
ize mRNAs to points of ligand stimulation.
The specifi  city in these mRNA localization responses is 
exhibited at multiple levels, including differential responses to 
growth-promoting versus growth-inhibiting ligands, differential 
responses to individual growth-promoting ligands, and even dif-
ferences within downstream signaling pathways for responses 
to an individual ligand. The microtubule-dependent changes in 
axonal mRNA levels were refl  ected by a reciprocal decrease 
or increase in cell body mRNA content, suggesting a ligand-
  dependent alteration in delivery of mRNAs from the cell body. 
However, our data do not completely exclude the possibility 
that localized mRNA stability may also contribute to axonal 
mRNA content. Likewise, it is possible that both mRNA trans-
port and stability are affected by distinct signaling pathways. 
Regardless of the specifi  c mechanism, our fi  ndings indicate that 
extracellular signals can change the local concentrations of axo-
nal mRNAs, which likely provides unique specifi  city to the lo-
calized protein synthetic responses.
Modulation of axonal mRNA levels is 
ligand speciﬁ  c
Although neurotrophins have been shown to increase the axonal 
localization of β-actin mRNA and local application of NGF and 
BDNF increases axonal levels of peripherin and vimentin mRNAs 
(Zhang et al., 1999, 2001; Willis et al., 2005), it has not been clear 
whether the neurotrophins or other ligands can decrease the axo-
nal localization of any mRNAs. By analyzing the axonal levels of 
a large panel of mRNAs, our study shows that the axonal local-
ization of individual mRNAs can be specifi  cally increased or de-
creased in response to different ligands. A localized redistribution 
of mRNAs within the axons could contribute to the focal deple-
tion of mRNAs as well as the translation product of localized 
eGFP
NLS/myrβ-actin mRNA adjacent to stimuli. With recent obser-
vations of the asymmetric redistribution of mRNA within growth 
cones in response to ligands (Leung et al., 2006; Yao et al., 2006) 
and the known short-range and bidirectional movements of RNA-
binding proteins within RNA processes (Kiebler and Bassell, 
2006), it is tempting to speculate that retrograde movement of 
mRNAs may also contribute to the decreased axonal mRNA lev-
els seen in the quantitative experiments used here. Thus, although 
the reverse transcription qPCR approach has given us a unique 
view of dynamic ligand-dependent changes in total axonal mRNA 
levels, further studies will be needed to fully dissect the contribu-
tions of mRNA degradation and retrograde movement within 
axons for determining localized mRNA levels.
Surprisingly, even when ligands induce similar trophic re-
sponses, as with the individual neurotrophins, particular mRNAs 
can be uniquely affected. NGF and BDNF showed overall simi-
lar changes in levels of individual axonal mRNAs, but the re-
sponse to NT3 appeared distinct. It is intriguing to speculate that 
differences in RNA transport refl  ect effects of these neurotrophins 
acting upon different neuronal subpopulations in the DRG 
(Snider, 1994). The ubiquitous expression of some mRNAs tested 
here (e.g., ribosomal proteins L22, L24, and S17;Amaldi et al., 
1989; Kaspar et al., 1993) argues that these transcripts should also 
be available for regulation in the NT3-responsive DRG neurons. 
The extensive overlap between NGF, BDNF, and NT3 signal 
transduction (Segal, 2003) suggests that mRNA localization is 
matched to the specifi  c ligand rather the overall trophic or tropic 
response to that ligand. Despite this overlap, tropic responses to 
neurotrophins can be distinct because cAMP can modify turning 
responses to NGF and BDNF, whereas cyclic guanosine mono-
phosphate can modify turning responses to NT3 (Song and Poo, 
1999). However, even with the similarities between NGF and 
BDNF, axonal levels of GAP-43 mRNA were uniquely altered 
by NGF. Because GAP-43 is expressed by all DRG neurons in 
the injury-conditioned cultures that were used here (Chong et al., 
1994; Smith and Skene, 1997), GAP-43 mRNA should certainly 
be available for regulation in the BDNF-responsive neurons.
Ligand-specifi  c effects were not limited to growth-promoting 
stimuli because DRG cultures treated with Sema3A and MAG 
also showed altered levels of individual mRNAs in the axons. 
Both the semaphorins and myelin inhibitors cause growth cone 
retraction in DRG neurons (Tanelian et al., 1997; Tang et al., 
2001). For all but one of the 50 transcripts tested (vimentin), 
Sema3A and MAG modulated the localization of different 
mRNAs or generated the opposite response for individual mRNAs 
when compared with the neurotrophins. This supports the con-
cept that axonal mRNA localization is tightly regulated with pe-
ripheral stimuli uniquely targeting individual mRNAs for focal 
increase or decrease along the axon.
Signal transduction pathways regulating 
axonal mRNA localization
Analyses of intracellular signaling showed further evidence of 
specifi  city for axonal mRNA localization mechanisms. Activa-
tion of Src family tyrosine kinases and Cdks by Sema3A in-
creases rates of retrograde and anterograde vesicular transport 
even in isolated axons, but it is not clear what cargo is being 
transported in response to Sema3A (Sasaki et al., 2002; Li et al., 
2004). Our data suggest that the local Sema3A stimulation of 
axons can direct the anterograde transport of cargo that includes 
mRNAs. The Sema3A-induced changes in axonal mRNA levels 
were sensitive to inhibition of Src family tyrosine kinases and 
Cdks (unpublished data), which is similar to what has been dem-
onstrated for Sema3A-dependent vesicular transport (Sasaki 
et al., 2002; Li et al., 2004).
The neurotrophin-dependent alterations in mRNA local-
ization reported here are Trk dependent for both the positively 
and negatively regulated mRNAs. For NGF, accumulation of the 
GFP reporter mRNA required retrograde transport. Although Trk 
activation is an obligate step in initiating retrograde signaling, 
there has been some debate about whether Trk is internalized 
and whether the retrogradely transported Trk includes ligand 
(Campenot and MacInnis, 2004; Zweifel et al., 2005). Our data 
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altering mRNA localization. We cannot completely exclude that 
NGF is not leached from the microparticles even with the cova-
lently bound ligands used here; however, we were previously un-
able to detect the release of noncovalently bound NGF from 
microparticles over the 4-h incubation period used in this study 
(Willis et al., 2005). Moreover, RNA localization changes seen 
with the local application of NGF to axons was qualitatively and 
quantitatively distinct from those seen with bath-applied NGF. 
Regardless of whether Trk and NGF internalize, our study argues 
that PI3K and MEK1 signaling cascades can uniquely regulate 
axonal mRNA localization. Because the NGF-dependent increase 
in β-actin mRNA was attenuated by the inhibition of Trk, PI3K, 
or MEK1, the neurotrophin’s regulation of β-actin mRNA local-
ization requires the sequential or convergent activation of PI3K 
and MEK1. The response of most other mRNAs to the neuro-
trophins was purely MEK1. Together, these data indicate that 
both divergent and convergent or sequential signaling cascades 
can specifi  cally control the local concentration of mRNAs into 
the axonal compartment. Although we clearly detected differ-
ences between localized and bath-applied neurotrophins, we 
have not distinguished whether the kinase activation occurs 
locally within axons or in the cell body. When axonal mRNA tar-
geting versus locally concentrating mRNAs at sites of stimulation 
is considered, one can hypothesize that PI3K and MEK1 may 
regulate the expression and/or activity of RNA-binding proteins 
needed for transport or docking of mRNAs and RNA granules.
Targeting mRNAs for axonal transport
The cDNA array analyses for identifi  cation of axonal transcripts 
show that >200 individual mRNAs can extend into these mam-
malian DRG processes. It is obvious that not all neuronal mRNAs 
extend into the axonal compartment of the cultured DRG neu-
rons used here. This implies that the neuron somehow knows 
which mRNAs to target for localization into these processes. For 
rat β-actin mRNA, the 3′ UTR containing the rat zipcode ele-
ment is suffi  cient to target a heterologous mRNA into adult DRG 
axons, similar to what has been demonstrated in other cell types 
(Hill et al., 1994; Kislauskis et al., 1994; Ross et al., 1997; Zhang 
et al., 1999; Farina et al., 2003). The other axonal mRNAs ana-
lyzed here likely contain localization elements, but their 3′ UTRs 
do not show any clear primary sequence homology to the β-actin 
zipcode (unpublished data). Interestingly, our data indicate that 
the DRG neurons not only know where to target mRNAs but also 
can be specifi  cally instructed where not to send individual 
mRNAs within the axon. The localization of mRNAs to focal 
sites of ligand stimulation is quite similar to dendritic mRNA 
localization, in which activated postsynaptic regions are tagged 
for RNA delivery (Steward et al., 1998; Steward and Halpain, 
1999; Aakalu et al., 2001; Tongiorgi et al., 2004).
Several lines of evidence indicate that localized mRNAs 
are also translationally regulated. Huttelmaier et al. (2005) 
showed that Src-dependent phosphorylation releases the zipcode 
binding protein from β-actin’s zipcode element, allowing trans-
lational activation of the mRNA. Because microtubule depoly-
merization completely blocked neurotrophin-dependent increase 
in β-actin mRNA by qPCR and prevented the localization of 
GFP
NLS/myrβ-actin in response to NGF, our studies suggest that 
localization of the encoding mRNA provides a key means to 
regulate axonal expression of this protein in DRG neurons. Our 
data do not preclude the possibility that the translation of axonal 
mRNAs is also tightly regulated by extracellular stimuli. This 
may indeed be the case for the majority of mRNAs with consti-
tutive axonal localization.
Verma et al. (2005) reported that the ability to regenerate 
axons correlates with the protein synthetic capacity of the axon. 
Our analyses of growth-promoting and growth-inhibiting ligands 
suggest that the synthetic capacity of growing axons is directly 
regulated by extracellular stimuli. The distinct effects of the 
neurotrophins versus MAG and Sema3A may point to antagonistic 
effects of these growth-promoting and growth-inhibiting stim-
uli on axonal mRNA levels. The growth-inhibitory effects of 
MAG can be overcome by priming neurons with neurotroph-
ins or agents that increase cAMP levels (Cai et al., 1999, 2001; 
Lu et al., 2004). Our data clearly show that growth-inhibiting stimuli 
from the central nervous system can regulate axonal mRNA lo-
calization and that these effects can be mitigated by offering the 
neuron antagonizing stimuli. Because MAG is a known growth 
inhibitory molecule in central nervous system white matter 
(Filbin, 2003), this raises the intriguing possibility that altera-
tions in mRNA localization may accompany the failed regenera-
tion of central nervous system axons. Our identifi  cation of the 
positive roles of neurotrophins in stimulating mRNA localiza-
tion in these regenerating adult sensory neurons in vitro should 
provide motivation to investigate a role for similar pathways 
in vivo. For example, TrkB signaling can enhance axonal regen-
eration in vivo (English et al., 2005), and this may depend, in part, 
on regulated mRNA localization and localized protein synthesis 
in regenerating sensory and motor nerves. The effect of MAG for 
focal depletion of axonal β-actin mRNA did not require retro-
grade transport; thus, tropic stimuli that can signal the cell body 
to modulate axonal mRNA levels may be able to overcome the 
local inhibitory effects of MAG on axonal protein synthesis.
Materials and methods
Pharmacological reagents
NGF (Harlan), BDNF, NT3 (Alomone Labs), MAG-Fc (R&D Systems), and 
Sema3A-AP (Nakajima et al., 2006) were covalently coupled to 15-μm-
  diameter polystyrene microparticles according to the manufacturer’s instruc-
tions (Polysciences). The following control proteins were also immobilized 
onto polystyrene microparticles or particles: BSA (Sigma-Aldrich) for NGF, 
BDNF, and NT3; human IgG-Fc (R&D Systems) for MAG-Fc; and AP for 
Sema3A-AP (provided by Y. Goshima, Yokohama University, Yokohama, 
Japan; Nakajima et al., 2006). Efﬁ  ciency of absorption was determined 
by Bradford assay for unbound protein. To determine the mechanisms in-
volved in modulation of axonal mRNA transport, DRG cultures were treated 
with the following pharmacological agents 30 min before the addition of 
immobilized ligands: 200 nM K252A (Calbiochem), 50 μM PD98059 
(Biomol), 50 μM LY294002 (Biomol), 10 μM Lavendustin (Biomol), 10 μM 
Olomucine (Biomol), 1 mM db-cAMP (Sigma-Aldrich), 10 μg/ml cyclohex-
imide (Sigma-Aldrich), 10 μM cytochalasin D (Sigma-Aldrich), and 1 μg/ml 
colchicine (Sigma-Aldrich). 50 nM EHNA (Sigma-Aldrich) was added to 
cultures 3 h before use.
Cell culture and axonal isolations
All animal surgeries and euthanasia were performed according to institu-
tional Animal Care and Use Committee guidelines under approved proto-
cols. Primary DRG cultures were prepared from Sprague Dawley rats that 
had been injury conditioned 7 d before by sciatic nerve crush at midthigh 
level (Smith and Skene, 1997). Dissociated cultures were prepared from CONTROL OF AXONAL MRNA LOCALIZATION • WILLIS ET AL. 977
L4-L5 DRGs as previously described (Twiss et al., 2000). Cultures were 
plated at moderate density on membrane inserts (for axonal isolation, see 
next paragraph) or at low density on coverslips (for live cell imaging and 
FISH analyses, see respective sections below).
The culture method for isolating DRG axons from cell bodies and 
nonneuronal cells has been previously described (Zheng et al., 2001; Willis 
et al., 2005). In brief, dissociated DRGs were plated into tissue culture 
inserts containing porous membranes (8-μm-diameter pores; BD Falcon), 
which were coated with poly-L-lysine (Sigma-Aldrich) and laminin (Upstate 
Biotechnology). Axons were isolated after 16–20 h in culture by scraping 
away the cellular content from the upper or lower membrane surfaces (yield-
ing axonal or cell body preparations, respectively). The purity of the axonal 
preparations was tested by RT-PCR for microtubule-associated protein 2, 
γ-actin, and β-actin mRNAs.
cDNA array analyses
Axonal RNA was isolated as described in the previous section, and the 
purity was conﬁ  rmed by RT-PCR for β-actin, γ-actin, and microtubule-
associated protein 2 (Fig. S1 A). 200 ng was used as a template for RT-PCR 
using the SMART PCR cDNA Synthesis kit (CLONTECH Laboratories, Inc.) 
to generate full-length double-stranded cDNA. Aliquots of the ampliﬁ  cation 
were removed from the PCR every third cycle from 12–30 cycles and used 
for Southern blotting. Southern blots were probed with 
32P-labeled β-actin 
cDNA to test for linearity (Fig. S1 B). The aliquot below where linearity was 
lost was used to generate a 
33P-labeled probe cDNA using the Advantage 
2 PCR System (CLONTECH Laboratories, Inc.) and hybridized to Atlas 
Plastic Rat 4K Microarrays (CLONTECH Laboratories, Inc.). Hybridization 
signals were detected by phosphorimaging, and results were analyzed us-
ing Atlas Image 2.7 software (CLONTECH Laboratories, Inc.). For compar-
ison between arrays, individual hits were normalized across the individual 
array and assigned a relative intensity.
Localized treatment of axons
The culture method for treatment of intact DRG axons has been previously 
described (Willis et al., 2005). In brief, DRGs were cultured on a porous 
membrane in the presence of 80 μM of the RNA synthesis inhibitor DRB 
throughout the culture period (Sigma-Aldrich). After 16–20 h in culture, the 
axonal compartments were selectively exposed to the protein-coupled micro-
particles by placing the inserts into dishes with shallower wells in which the 
bottom surface of the insert directly contacted coated microparticles along 
the bottom of the wells. Microparticles of 15 μm diameter were used for 
these stimulations to restrict any passage through the 8-μm pores of the 
membrane, which limited stimulation to the axonal compartment. After 4 h 
of treatment, membranes were rinsed in PBS, and the axonal compartment 
was isolated as described in Cell culture and axonal isolations. RNA was 
extracted from the fractionated cultures using the RNAqueous Micro kit 
(Ambion) and quantiﬁ  ed using ﬂ  uorometry with the RiboGreen reagent 
(Invitrogen). To normalize the axonal mass between samples, ﬂ  ow through 
from the afﬁ  nity-based RNA isolation was used to measure the protein con-
tent of the axonal samples by ﬂ  uorometry with the NanoOrange reagent 
(Invitrogen). All axonal RNA samples were normalized to protein content 
before RT-PCR analyses (Willis et al., 2005).
To visualize the localized effects of immobilized ligand exposure to 
axons, 4.5-μm microparticles were used. For live cell imaging (see Live cell 
imaging section below), ﬂ  uorescent microparticles were added to cultures 
growing on poly-L-lysine/laminin chambered coverslips. For the FISH stud-
ies (see FISH section below), 7-d injury-conditioned DRGs were cultured 
overnight in the presence of carboxylated polystyrene microparticles 
with immobilized neurotrophins, MAG, or Sema3A. In these experiments, 
the ligand-immobilized microparticles were coupled directly to the laminin 
surface, which prevented them from being washed away in subsequent 
FISH/immunoﬂ  uorescence steps. For this, ligands were coupled to micro-
particles overnight according to the manufacturer’s protocol (Polysciences). 
Microparticles were then added to the coated coverslips for 4 h. Unreacted 
sites were blocked with ethanolamine, and coverslips were washed and 
used for standard DRG culture.
Analysis of axonal RNAs
For analyses of axonal transcripts, normalized axonal RNAs ( 50 ng 
each) were used as a template for reverse transcription using the iScript RT 
kit (Bio-Rad Laboratories). The reverse transcription reactions were diluted 
10-fold, and the purity of each axonal preparation was assessed by RT-PCR 
for γ-actin and microtubule-associated protein 2 mRNAs, which are ex-
pressed at high levels in rat DRG cultures but are excluded from the axo-
nal compartment as previously described (Willis et al., 2005). Validated 
axonal RNA preparations were then used for reverse transcription qPCR. 
In brief, reverse-transcribed axonal RNA was ampliﬁ   ed using the Prism 
7900HT sequence detection system (Applied Biosystems) with 2× SybrGreen 
Master Mix (QIAGEN) according to the manufacturer’s standard cycling 
parameters. Rat brain RNA was used as a template to generate standard 
curves for all primer pairs. A robotic system (Biomek 2000;   Beckman 
Coulter) was used to standardize the pipetting of samples and reagents into 
384-well plates for qPCR. All samples were assayed in quadruplicate from 
at least three independent experiments each. In addition to controlling for 
axonal number based on protein content, the relative levels of each tran-
script were normalized to the 12S mitochondrial ribosomal RNA control by 
the comparative threshold method (Ct) to provide an internal control for 
  reverse transcription efﬁ  ciency and axonal content. RNA values are ex-
pressed relative to control (BSA for NGF, BDNF, and NT3 treatments; Fc 
for MAG-Fc treatment; and AP for Sema3A treatment).
Metabolic labeling of RNA
Injury-conditioned DRGs were cultured overnight ± 80 μM DRB. Culture 
medium was then supplemented with 125 mCi/ml α-[
32P]UTP (GE Health-
care). After a 4-h labeling period, total RNA was extracted and quantiﬁ  ed 
by ﬂ  uorometry as described in Localized treatment of axons. The speciﬁ  c 
activity was determined by liquid scintillation counting. These labeled 
RNA samples (2 μg each) were electrophoresed in a 6% acrylamide 
gel. After electrophoresis, the gel was stained with ethidium bromide, 
imaged under UV to verify RNA loading and integrity, dried, and used 
for autoradiography.
cDNA constructs for expressing chimeric mRNAs
Chimeric reporter cDNA constructs were generated by replacing the 
3′ UTR of the αCamKII-eGFP
NLS/myr constructs (provided by E. Schuman, Cal-
ifornia Institute of Technology, Pasadena, CA; Aakalu et al., 2001) with 
that of the rat γ-actin and β-actin mRNAs. cDNA encoding 3′ UTRs of 
these rat mRNAs were isolated by RT-PCR from rat brain RNA template 
using the following primers engineered with Not1 and Xh1 restriction 
sites (actin components are underlined): sense β-actin (5′-A  A  G  G  A  A  A-
A  A  A  G  C  G  G  C  C  G  C  G  C  G  G  A  C  T  G  T  T  A  C  T  G  A  G  C  T  G  C  G  -3′), antisense β-actin 
(5′-T  T  T  A  A  C  T  C  G  A  G  T  T  T  A  T  T  C  G  G  T  C  T  C  A  C  G  T  C  A  G  T  -3′), sense γ-actin (5′-A  A  G-
G  A  A  A  A  A  A  G  C  G  G  C  C  G  C  G  C  A  G  A  T  G  G  A  C  T  G  A  G  C  A  G  G  T  G  C  C  A  G  G  -3′), 
and antisense γ-actin (5′-T  T  T  A  A  C  T  C  G  A  G  C  T  T  T  T  A  T  T  T  C  T  C  T  T  T  A  C  A  C  A  A  T  -3′). 
PCR products were cloned into pTOPO vector (Invitrogen) and sequenced. 
Sequences were compared with γ-actin and β-actin 3′ UTRs published in 
GenBank; veriﬁ  ed cDNA inserts were subcloned into the eGFP construct 
to generate peGFP
NLS/myrγ-actin and peGFP
NLS/myrβ-actin. These plasmids 
were tested for expression and subcellular localization of the encoded 
eGFP by transfecting naive DRG cultures using LipofectAMINE 2000 
(Invitrogen). Once validated, the eGFP
NLS/myr plus 3′ UTR cassettes were 
digested with Nru1 and Xho1 and subcloned into Pme1 and Xho1 sites of 
pVQ-CMV-kNpA shuttle plasmid (Viraquest) for the generation of AV. The 
in vitro recombination and generation as well as packaging and titering 
of AVeGFP
NLS/myrγ-actin and AVeGFP
NLS/myrβ-actin were provided as a fee 
for service (Viraquest).
For adenoviral-based expression, dissociated DRG neurons were 
exposed to 150 MOI AVeGFP
NLS/myrβ-actin or AVeGFP
NLS/myrγ-actin for 
15 min at 37°C after the last trituration step in dissociating DRGs for culture. 
Cultures were plated onto chambered coverglass (Nalgene) coated with 
poly-L-lysine and laminin. Cultures were grown for 16–20 h when ≥70% of 
cells showed GFP expression.
siRNA transfection
Dynein-based transport was diminished using ON-TARGET Plus SMART-
pool siRNA targeting Dync1h1 (GenBank/EMBL/DDBJ accession no. 
NM_019226; Dharmacon). siGLO-Red reagent (Dharmacon) was used for 
identifying transfected neurons in the live cell imaging experiments (see 
Live cell imaging section below). After 12 h in vitro, DRG cultures were 
transfected with siRNAs using DharmaFECT3 as per the manufacturer’s in-
structions (Dharmacon). The cultures were exposed to 50 nM of total siRNA 
(25 nM Dync1h1 and 25 nM siGLO-Red) plus 1.0 μl DharmaFECT3 in a 
total culture volume of 1 ml. After 24 h, the culture medium was replaced, 
and the cells were allowed to grow for 72 h.
Effectiveness of the siRNAs for depleting Dync1h1 was analyzed 
by immunoblotting
For this, control and siRNA-treated cultures were lysed in radioimmuno-
precipitation assay buffer (0.1% SDS, 50 mM Tris-Cl, pH 6.8, 150 mM NaCl, 
0.5% NP-40, and 2 mM EDTA), cleared by centrifugation, and normalized 
for protein content by Bradford assay (Bio-Rad Laboratories). Lysate were 
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diﬂ  uoride membrane (Willis et al., 2005). Blots were blocked in Tris-buff-
ered saline with 0.1% Tween 20 (TBST) plus 5% nonfat dry milk for 1 h and 
then incubated overnight at 4°C in rabbit anti–dynein HC antibody (1:200; 
Santa Cruz Biotechnology, Inc.). Blots were rinsed several times in TBST 
and incubated with HRP-conjugated anti–rabbit IgG (1:5,000; Cell Signal-
ing) for 1 h at room temperature. Blots were washed for 30 min in TBST 
and developed with ECL (GE Healthcare).
Live cell imaging
NGF-coated and/or MAG-coated Fluoresbrite YO Carboxylate Micro-
spheres (4.5 or 6.0 μm; Polysciences) were added to cultures of infected 
DRGs at a low density and allowed to settle for 20 min before imaging. 
GFP-expressing neurons that contacted a ﬂ  uorescent protein-bound micro-
particle were imaged by confocal microscopy using an inverted laser-
scanning system (TCS/SP2 LSM; Leica) on an inverted microscope 
(DMIRE2; Leica) ﬁ   tted with an environmental chamber to maintain a 
  humidiﬁ  ed temperature of 37°C with 5% CO2. A 63× NA 1.4 oil immersion 
objective (Leica) was used for all imaging. The pinhole was set for 5 airy U 
to allow the acquisition of emission over the full thickness of the axon. The 
488-nm laser line was used to excite eGFP and ﬂ  uorescent microparticles; 
eGFP emission was collected at 498–530 nm, and microparticle ﬂ  uores-
cence was collected at 575–600 nm. For time-lapse sequences, images 
were collected every minute over 50 min using the LCS confocal software 
package (Leica); the resultant avi ﬁ  le was converted to mov using the 
QuickTime media player (Apple Computer) and Sorenson compression 
(Sorenson Media). All image sequences were subjected to identical post-
processing for γ correction.
ImageJ (National Institutes of Health [NIH]) was used to quantify 
GFP signal intensity in these video sequences using original, unprocessed 
gray-scale images matched for laser intensity, photo multiplier tube volt-
age, and offset. For this, pixels/micrometer
2 were quantiﬁ  ed in a 10-μm 
axon segment spanning 5 μm proximally and distally from the center of the 
particle. The mean signal intensity was determined from ﬁ  ve or more axons 
per condition for at least three separate experiments. Because mRNAs 
could accumulate before initiation of the imaging sequence, we concen-
trated our analyses on the t = 50 min images. Unless otherwise indicated, 
the ratio of mean pixels/micrometer
2 of t = 50 min for NGF- and MAG 
Fc–treated cultures versus BSA- and IgG Fc–treated cultures, respectively, 
± SD is presented. For the db-cAMP–, EHNA-, and siRNA-treated cultures, 
NGF and MAG signals were compared with similarly treated control cul-
tures (BSA for NGF and IgG Fc for MAG-Fc) for the t = 50 min image.
Effects of siRNAs and EHNA on axonal transport were visualized by 
live cell imaging of LysoTracker dye (Invitrogen). LysoTracker was added at 
a ﬁ  nal concentration of 50 nM and incubated for 20 min at 37°C. Medium 
was then changed, and vesicular movement was imaged over 2.5 min, with 
image acquisition every 5 s. The presence of siGLO signal in the neuronal 
cell body was used to identify siRNA-transfected neurons. To visualize axo-
nal protein synthesis, infection with the AV-eGFP
NLS/myrβ-actin was concur-
rent with the siRNA transfection. The NGF- or MAG-coated microparticles 
were added to cultures, and effects on local synthesis were imaged as de-
scribed in the beginning of this section.
FISH
FISH was performed as previously described with minor modiﬁ  cations for 
the DRG cultures (Bassell et al., 1998). Oligonucleotide probes comple-
mentary to β-actin mRNA (at positions 3,187–3,138 and 3,446–3,495), 
peripherin (at positions 868–917, 1,263–1,312, and 1,382–1,431), and 
Kv3.1a (at positions 3,341–3,390 and 3,045–3,094) were designed us-
ing Oligo6 software (Molecular Biology Insights) and checked for homol-
ogy to other mRNAs by BLAST. Probes were synthesized with amino group 
modiﬁ  cations at four positions each and labeled with digoxigenin succin-
amide ester as per manufacturer’s instructions (Roche). The DRG cultures 
were ﬁ  xed in buffered 4% PFA, equilibrated in 1× SSC with 40% form-
amide, and incubated at 37°C for 12 h in hybridization buffer (40% form-
amide, 0.4% BSA, 20 mM ribonucleoside vanadyl complex, 10 mg/ml 
salmon testes DNA, 10 mg/ml Escherichia coli tRNA, and 10 mM sodium 
phosphate in 1× SSC) containing 20 ng of probe. Hybridization was de-
tected by immunoﬂ   uorescence using Cy3-conjugated mouse antidigoxi-
genin (1:1,000; Jackson ImmunoResearch Laboratories); neuroﬁ  lament 
protein was detected by colabeling with chicken anti–neuroﬁ  lament heavy 
subunit (1:1,000; Chemicon) followed by FITC-conjugated anti–chicken 
antibody (1:500; Jackson ImmunoResearch Laboratories).
Quantitative imaging of FISH signals was performed on an upright 
epiﬂ  uorescent microscope (DM RXA2; Leica) with a CCD camera (ORCA-ER; 
Hamamatsu). All images were acquired using OpenLab 5.0 software (Impro-
vision) and matched exposure time, gain, and offset with no postprocessing. 
All quantitative measurements were performed on the original 16-bit images 
using ImageJ (NIH). The point of the axon corresponding to the center of the 
particle was used as a reference point for measuring pixel intensity of the 
Cy3 emission. A 5-μm segment of axon corresponding to 2.5 μm proximal 
and distal to the particle center was used as the zero point. From this, the 
pixels/micrometer
2 was quantiﬁ  ed in three bins proximal to and distal to the 
particle center (5-μm length each plus 5-μm bin at particle center). Back-
ground was subtracted from the intensity values, and subtracted signal inten-
sity in each 5-μm bin was normalized to the mean intensity over the entire 
35-μm axon region that was measured.
Online supplemental material
Table S1 shows array-based identiﬁ  cation of axonal mRNAs with the mean 
intensity of four axonal RNA preparations. Fig. S1 shows the purity of the 
axonal RNA used to generate the cDNA to probe the arrays (A) and con-
ﬁ  rms the linear ampliﬁ  cation of the cDNA by virtual Northern blotting (B). 
Fig. S2 shows 
32P[UTP] labeling of DRG cultures ± DRB to conﬁ  rm the ef-
fectiveness of RNA polymerase II inhibition (A) and presents a Western blot 
conﬁ  rming the reduced levels of dynein heavy chain in DRGs treated with 
the Dync1h1 siRNA for 72 h (B). Fig. S3 shows cultured DRGs infected with 
either eGFP
NLS/myrβ-actin 3′ UTR or eGFP
NLS/myrγ-actin 3′ UTR reporter con-
structs. Fig. S4 shows the cultured DRG response to immobilized sources 
of NGF (A), BSA (B), MAG-Fc (D), or IgG-Fc (E). The ﬁ  gure also shows that 
pretreatment with K252A before the addition of immobilized NGF shows 
a requirement for TrkA signaling (C) and that pretreatment with db-cAMP 
before the addition of immobilized MAG-Fc shows a reversal of MAG’s 
effects by elevation of cAMP signaling (F). Video 1 shows live cell imaging 
of a neuron exposed to immobilized NGF (video of cell shown in Fig. 5 A). 
Video 2 shows a neuron pretreated with PD98059 before NGF exposure 
(video of cell shown in Fig. 5 B). Video 3 shows a DRG pretreated with 
colchicine before NGF exposure (video of cell shown in Fig. 5 C). Video 4 
shows a neuron transfected with Dync1h1 siRNA and stained with Lyso-
Tracker to show reduced retrograde but not anterograde transport. Video 5 
shows a neuron treated with the dynein inhibitor EHNA and stained with 
LysoTracker to show reduced retrograde movement. Video 6 shows a neuron 
exposed to immobilized MAG-Fc (video of cell shown in Fig. 6 A). Video 7 
shows a neuron treated with db-cAMP before exposure to immobilized 
MAG-Fc (video of cell shown in Fig. 6 C). Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.200703209/DC1.
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